Q4 2022 Earnings

Events

Investor Relations

Press Releases

04 Mar '24
Veradigm Completes Acquisition of ScienceIO
CHICAGO --(BUSINESS WIRE)--Mar. 4, 2024-- Veradigm Inc. (OTCMKTS: MDRX) (the “Company”), a leading provider of healthcare data and technology products and solutions, today announced that it has completed its acquisition of ScienceIO, a leading AI platform and foundation model provider for the
04 Mar '24
Veradigm to Participate in Barclays 26th Annual Global Healthcare Conference
CHICAGO --(BUSINESS WIRE)--Mar. 4, 2024-- Veradigm Inc. (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions announced today that Dr. Yin Ho , Veradigm interim Chief Executive Officer and board member, Lee Westerfield , interim Chief Financial Officer, and Will Manidis ,
28 Feb '24
Veradigm to Participate in TD Cowen Annual Health Care Conference
CHICAGO --(BUSINESS WIRE)--Feb. 28, 2024-- Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology products and solutions, today announced that Dr. Yin Ho , Veradigm interim Chief Executive Officer, and Lee Westerfield , interim Chief Financial Officer, will present at
28 Feb '24
Veradigm Receives Expected Delisting Notice from Nasdaq
Continues to Work Diligently Towards Regaining Compliance CHICAGO --(BUSINESS WIRE)--Feb. 28, 2024-- Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology products and solutions, announced today that, as expected, it received a notice from The Nasdaq Stock Market LLC

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Contact Investor Relations

Jenny Gelinas
Vice President, Investor Relations
jenny.gelinas@veradigm.com